Medication info
Nomaropin Tablet 5/50 mg

Nomaropin Tablet 5/50 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201504319 · Approved 2015.06.30 · Insurance code 657805610

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: This medicine is not recommended for patients with reduced effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: This medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or losartan. It is also applied as initial treatment in stage 2 hypertension patients who require combination therapy to achieve treatment goals. This helps effectively manage blood pressure, reduce the risk of cardiovascular complications, and improve health.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: This medicine is not recommended for patients with reduced effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: This medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Caution is required when this medication is administered to patients with decreased effective blood volume, for example, in patients taking diuretics, as hypotension may occur. It should not be administered to patients with hypersensitivity to the active ingredients, those who are pregnant or likely to become pregnant, breastfeeding women, patients with severe liver dysfunction, patients with severe aortic stenosis, and patients in shock. Caution is advised for patients with reduced effective blood volume, patients with strict salt restrictions, patients with moderate to severe renal impairment, and patients with hyperkalemia. Adverse reactions such as dizziness, headache, drowsiness, weakness, peripheral edema, dyspepsia, pruritus, palpitations, orthostatic hypotension, dyspnea may occur, and patients should consult a healthcare professional immediately if any abnormal symptoms arise. Since blood pressure may drop causing dizziness while taking this medication, it is advisable to avoid hazardous activities such as working at heights or driving. Patients with liver or kidney impairment may need dosage adjustment, requiring regular check-ups. This medication can raise potassium levels, so when taken with potassium-sparing diuretics or potassium supplements, serum potassium levels should be carefully monitored. Combining with other antihypertensive medications may enhance blood pressure-lowering effects, thus should be used cautiously under the direction of healthcare professionals. Pregnant or breastfeeding women should avoid this medication, and it should be discontinued immediately upon confirmation of pregnancy. Safety and efficacy have not been established for children under 18 years of age, and its use is not recommended. Overdosage can result in severe hypotension and tachycardia, so dosing must be strictly adhered to, and medical assistance should be sought immediately if symptoms occur. This medication should be kept out of reach of children and should not be transferred to other containers for safety.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • asthenia
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
Show 172 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vasculitis
  • tension increase
  • sensory loss
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habit
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin pigmentation
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • hypotension
  • sinus node block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • erythema of the skin
  • maculopapular rash
  • heaviness
  • heat sensation
  • reduced glucose tolerance
  • weakness
  • muscle spasm
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory diminution
  • decreased libido
  • memory impairment
  • migraine
  • neural excitability
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • erythema
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste aberration
  • tinnitus
  • decreased vision
  • urethral infection
  • hypotension
  • shock
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • intestinal angioedema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • hyperkalemia
  • hyponatremia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is also advisable to keep it at room temperature, that is, between 1 degree and 30 degrees Celsius. This helps to maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.